Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Update

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) was the target of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 132,800 shares, a decrease of 69.7% from the November 30th total of 439,000 shares. Based on an average daily volume of 118,279,600 shares, the short-interest ratio is presently 0.0 days.

Therapeutic Solutions International Stock Down 25.0 %

OTCMKTS TSOI traded down $0.00 during trading on Thursday, hitting $0.00. 5,272,137 shares of the company’s stock traded hands, compared to its average volume of 21,355,861. Therapeutic Solutions International has a 12-month low of $0.00 and a 12-month high of $0.00.

Therapeutic Solutions International Company Profile

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.